1. Home
  2. SILK

SILK

Silk Road Medical Inc.

Logo Silk Road Medical Inc.

Health Care

Medical/Dental Instruments

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Silk Road Medical Inc is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has a new approach for the treatment of carotid artery disease called transcarotid artery revascularization, or TCAR, which it seeks to establish as the standard of care. TCAR relies on two novel concepts - minimally-invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines novel endovascular techniques with fundamental surgical principles. TCAR using its portfolio of products has been clinically demonstrated to reduce the upfront morbidity and mortality risks commonly associated with carotid endarterectomy. The company generates all of its revenue in the United States.

Founded: 2007 Country:
United States
United States
Employees: N/A City: SUNNYVALE
Market Cap: 733.0M IPO Year: 2019
Target Price: $23.90 AVG Volume (30 days): 834.8K
Analyst Decision: Buy Number of Analysts: 12
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.44 EPS Growth: N/A
52 Week Low/High: $6.08 - $46.57 Next Earning Date: 04-30-2024
Revenue: $177,134,000 Revenue Growth: 27.77%
Revenue Growth (this year): 12.82% Revenue Growth (next year): 11.16%

Share on Social Networks: